Rankings
▼
Calendar
NUVB Q2 2022 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena
NUVB
Nuvation Bio Inc.
$2B
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$38M
Net Income
-$35M
EPS (Diluted)
$-0.16
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$27M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$720M
Total Liabilities
$27M
Stockholders' Equity
$693M
Cash & Equivalents
$102M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$38M
-$20M
-85.3%
Net Income
-$35M
-$19M
-80.3%
← FY 2022
All Quarters
Q3 2022 →